On a per-share basis, the
The biopharmaceutical company posted revenue of
In the final minutes of trading on Thursday, the company's shares hit
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a
Automated Insights, source